Individualizing approaches to surveillance mammography in older breast cancer survivors
Active Project Grant Awarded Last action
- Award ID
- R01AG089237
- Recipient
-
Dana-Farber Cancer Institute, Inc. UEI DPMGH9MG1X67
- Awarding agency
-
National Institute on Aging
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,777,442
Award facts
- Assistance listing
- 93.866 Aging Research
- Completion date 37% complete
- Originally
- Place of performance
- Boston, MA 02215, USA
Award details come from USAspending.gov.
Description
- Abstract
- Evidence-based approaches to surveillance mammography for older breast cancer survivors do not exist. Data suggest a life expectancy of ~10 years is necessary for early detection to translate into a small survival benefit. Conversely, the harms of mammography persist and are immediate, including false positives, overdiagnosis, and related over-treatment. Currently, mammography use in survivors is high, even when life expectancy is limited. As part of a national cancer institute (NCI) R21, the "are mammograms still right for me?" shared decision making (SDM) toolkit was developed to support SDM between clinicians and older women around when to discontinue surveillance mammography. The SDM toolkit is designed for any survivorship setting and contains clinician-facing expert-consensus guidelines, talking points, and a companion patient guide on the benefits and harms of surveillance mammography. What remains lacking and critically needed is evidence as to the effectiveness of the SDM toolkit in decreasing mammography use in those who are more likely to experi- ence harm than benefit. The long-term goal is to accelerate the development and implementation of breast cancer survivorship guidelines tailored to individuals. The overall objective for this application is to determine the effects of the SDM toolkit on mammography use, decision quality, and mammography knowledge in breast cancer survivors aged ≥80, an age where median life expectancy is
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $833,902 | |
| Original award | $943,540 |
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| University Of California, LOS Angeles | $85,239 | |
| H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc. | $78,987 | |
| Mayo Clinic | $76,859 | |
| University Of Rochester | $74,163 | |
| University Of California, LOS Angeles | $105,399 | |
| H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc. | $88,424 | |
| Mayo Clinic | $85,897 | |
| Beth Israel Deaconess Medical Center, Inc. | $116,881 | |
| University Of Rochester | $82,787 |
Quick answers
Who received award R01AG089237?
R01AG089237 was awarded to Dana-Farber Cancer Institute, Inc. by National Institute on Aging (National Institutes of Health) on September 5, 2024.
How much is award R01AG089237 worth?
$1,777,442 has been obligated on R01AG089237.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award